MARKET

MASI

MASI

Masimo Corp
NASDAQ

Real-time Quotes | Nasdaq Last Sale

141.46
-0.85
-0.60%
Closed 18:03 05/24 EDT
OPEN
140.12
PREV CLOSE
142.31
HIGH
142.85
LOW
137.64
VOLUME
916.60K
TURNOVER
--
52 WEEK HIGH
305.21
52 WEEK LOW
112.07
MARKET CAP
7.85B
P/E (TTM)
36.54
1D
5D
1M
3M
1Y
5Y
Here's Why You Should Retain Change Healthcare (CHNG) Stock
Change Healthcare (CHNG) continues to benefit from strategic deals. However, intense competition remains a woe.
Zacks · 19h ago
Thermo Fisher (TMO) to Advance Precision Medicine in Qatar
Thermo Fisher's (TMO) collaboration with Qatar Genome Program will utilize the power of genomics to enhance the standard of healthcare for the Qatari population.
Zacks · 19h ago
What's in the Cards for Medtronic (MDT) in Q4 Earnings?
Medtronic's (MDT) Cardiovascular business is expected to have gained share in both high and low power devices in Q4.
Zacks · 1d ago
New Study Finds That Masimo PVi® May Be Useful in Helping ER Doctors Determine the Severity of Asthma Attacks in Pediatric Patients
NEUCHATEL, Switzerland, May 23, 2022--A study investigated the ability of Masimo PVi® to guide ER triage decisions for pediatric patients with obstructive respiratory disease.
Business Wire · 2d ago
BRIEF-Masimo Corp Entered Into First Amendment To Credit Agreement
reuters.com · 4d ago
Can Masimo (MASI) Run Higher on Rising Earnings Estimates?
Masimo (MASI) shares have started gaining and might continue moving higher in the near term, as indicated by solid earnings estimate revisions.
Zacks · 4d ago
PerkinElmer (PKI) Boosts Genomic Testing Portfolio With urWGS
PerkinElmer's (PKI) urWGS will improve outcomes for critically ill patients in NICUs and PICUs.
Zacks · 4d ago
Here's Why You Should Hold on to DexCom (DXCM) Stock Now
DexCom (DXCM) continues to benefit from a solid product portfolio and a strong international presence. However, supply constraints remain a woe.
Zacks · 5d ago
More
No Data
Learn about the latest financial forecast of MASI. Analyze the recent business situations of Masimo Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 6 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

16.67%Strong Buy
16.67%Buy
66.67%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average MASI stock price target is 156.25 with a high estimate of 205.00 and a low estimate of 130.00.
High205.00
Average156.25
Low130.00
Current 141.46
EPS
Actual
Estimate
0.300.600.911.21
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 717
Institutional Holdings: 53.57M
% Owned: 96.52%
Shares Outstanding: 55.50M
TypeInstitutionsShares
Increased
178
1.70M
New
89
423.08K
Decreased
151
1.78M
Sold Out
39
216.64K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
-0.88%
Healthcare Equipment & Supplies
-0.38%
Key Executives
Chairman/Chief Executive Officer/Director
Joseph Kiani
Chief Financial Officer/Executive Vice President
Micah Young
Corporate Executive
Kevin Duffy
Chief Operating Officer
Bilal Muhsin
Executive Vice President/General Counsel/Secretary
Tom Mcclenahan
Executive Vice President
Tao Levy
Independent Director
H Michael Cohen
Independent Director
Adam Mikkelson
Independent Director
Craig Reynolds
Independent Director
Julie Shimer
No Data
No Data
About MASI
Masimo Corporation is a global medical technology company that develops, manufactures, and markets noninvasive technologies and hospital automation solutions. Its patient monitoring solution that incorporates a monitor or circuit board, single-patient use or reusable sensors, software and cables. The Company’s main products include Masimo Signal Extraction Technology (SET) pulse oximetry. Its product offerings include noninvasive monitoring of blood constituents with an optical signature, optical regional oximetry monitoring, electrical brain function monitoring, acoustic respiration monitoring, exhaled gas monitoring, nasal high flow ventilation, minimally invasive neuromodulation technology for pain. It sells its products hospitals, emergency medical service (EMS) providers, home care providers, long-term care facilities, physician offices, veterinarians and consumers through direct sales force, distributors and original equipment manufacturers (OEM) partners.

Webull offers kinds of Masimo Corporation stock information, including NASDAQ:MASI real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, MASI stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading MASI stock methods without spending real money on the virtual paper trading platform.